Zilokem 80 Tablet contains Azilsartan medoxomil 80 mg, an angiotensin II receptor blocker (ARB) indicated for the treatment of hypertension. By selectively inhibiting the binding of angiotensin II to the AT1 receptor, Zilokem promotes vasodilation, reduces aldosterone secretion, and decreases sodium and water retention, thereby lowering blood pressure. This medication is effective in managing essential hypertension and reducing the risk of cardiovascular events associated with elevated blood pressure. Zilokem 80 is typically administered once daily, with or without food, and dosage adjustments should be individualized based on patient response and tolerability. It is contraindicated in patients with hypersensitivity to azilsartan or any component of the formulation, and caution is advised in those with renal impairment, hepatic dysfunction, or volume depletion. Common adverse effects may include dizziness, fatigue, and hypotension. Regular monitoring of blood pressure, renal function, and electrolytes is recommended during therapy. Zilokem 80 should not be used concomitantly with aliskiren in patients with diabetes or renal impairment. This medication offers an effective and well-tolerated option for blood pressure control, contributing to the prevention of stroke, myocardial infarction, and other hypertensive complications.